Information only, not medical advice. Talk to your doctor or pharmacist.
FDA and Health Canada
NewRx Radar lists original FDA new molecular entity approvals and Health Canada human drug products that are the first dated DPD record for their active ingredient, from January 1, 2025. Each row links to the government record. If a condition cannot be mapped, it stays Unclassified.
Health Canada
UnclassifiedAFICAMTEN 5 MG; AFICAMTEN 10 MG; AFICAMTEN 15 MG; AFICAMTEN 20 MG
This DPD record had no therapeutic class in the pull, so the condition is Unclassified.
Health Canada
UnclassifiedNERANDOMILAST 9 MG; NERANDOMILAST 18 MG
Therapeutic class L04AA61 NERANDOMILAST did not match one condition rule, so the condition is Unclassified.
Health Canada
UnclassifiedREMIBRUTINIB 25 MG
Therapeutic class L04AA60 REMIBRUTINIB did not match one condition rule, so the condition is Unclassified.
Health Canada
UnclassifiedTRENIBOTULINUMTOXINE 1400 UNIT
Therapeutic class M03AX01 BOTULINUM TOXIN did not match one condition rule, so the condition is Unclassified.
Health Canada
UnclassifiedDENECIMIG 1.6 MG; DENECIMIG 4 MG; DENECIMIG 9 MG; DENECIMIG 20 MG; DENECIMIG 46 MG
Therapeutic class B02BX OTHER SYSTEMIC HEMOSTATICS did not match one condition rule, so the condition is Unclassified.
Health Canada
UnclassifiedDONIDALORSEN (DONIDALORSEN SODIUM) 80 MG
Therapeutic class B06AC09 DONIDALORSEN did not match one condition rule, so the condition is Unclassified.
FDA
UnclassifiedTIRATRICOL 350MCG
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
FDA
UnclassifiedZILURGISERTIB FUMARATE EQ 25MG BASE
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.